ReviewFrontiers in immunology2022

Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review.

Wei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.